furosemide has been researched along with Coronary Disease in 39 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This is a prospective randomized controlled trial to study the efficacy and safety of Shenfu injection combined with furosemide in the treatment of coronary heart disease and chronic heart failure." | 9.41 | Shenfu injection combined with furosemide in the treatment of chronic heart failure in patients with coronary heart disease: A protocol of randomized controlled trial. ( Gao, Y; Tan, X; Zhu, R, 2021) |
| "Severe tachycardia, ventricular ectopy, and sodium retention manifested by hemodynamic deterioration developed with hydralazine hydrochloride therapy in chronic coronary heart disease with congestive failure refractory to digitalis, diuretics, and nitrates." | 7.66 | Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy. ( Amsterdam, EA; DeMaria, AN; Laslett, LJ; Mason, DT, 1978) |
| "Ibopamine is a novel oral dopamine analogue with positive inotropy and diuretic effects." | 6.67 | [Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure]. ( Gerzer, R; Theisen, K; Wehling, M; Weil, J; Zimmermann, J, 1990) |
| "This is a prospective randomized controlled trial to study the efficacy and safety of Shenfu injection combined with furosemide in the treatment of coronary heart disease and chronic heart failure." | 5.41 | Shenfu injection combined with furosemide in the treatment of chronic heart failure in patients with coronary heart disease: A protocol of randomized controlled trial. ( Gao, Y; Tan, X; Zhu, R, 2021) |
| "Severe tachycardia, ventricular ectopy, and sodium retention manifested by hemodynamic deterioration developed with hydralazine hydrochloride therapy in chronic coronary heart disease with congestive failure refractory to digitalis, diuretics, and nitrates." | 3.66 | Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy. ( Amsterdam, EA; DeMaria, AN; Laslett, LJ; Mason, DT, 1978) |
| " On long term evaluation in an open design (Phase II), wherein Phase I participants continued Terminalia Arjuna in fixed dosage (500 mg 8-hourly) in addition to flexible diuretic, vasodilator and digitalis dosage for 20-28 months (mean 24 months) on outpatient basis, patients showed continued improvement in symptoms, signs, effort tolerance and NYHA Class, with improvement in quality of life." | 2.68 | Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure. ( Bharani, A; Bhargava, KD; Ganguly, A, 1995) |
| "Ibopamine is a novel oral dopamine analogue with positive inotropy and diuretic effects." | 2.67 | [Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure]. ( Gerzer, R; Theisen, K; Wehling, M; Weil, J; Zimmermann, J, 1990) |
| "In 50 patients with chronic congestive heart failure (CCHF, III or IV class), aged 62." | 2.67 | [Effect of vasodilator agents on the character and incidence of cardiac arrhythmia in chronic heart failure]. ( Bechler-Lisińska, J; Cholewa, M; Górski, L; Markiewicz, K, 1990) |
| "The treatment of acute cardiogenic pulmonary edema is associated with the return of hypo-oncotic fluid from the interstitial compartment back into the intravascular compartment with expansion of plasma volume and reduction of colloid osmotic pressure and hemoglobin concentration." | 1.26 | Effect of afterload reduction on plasma volume during acute heart failure. ( Henning, RJ; Weil, MH, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (76.92) | 18.7374 |
| 1990's | 5 (12.82) | 18.2507 |
| 2000's | 3 (7.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (2.56) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y | 2 |
| Zhu, R | 1 |
| Tan, X | 1 |
| POLETTI, T | 1 |
| BELLARDO, G | 1 |
| MASCARELLO, M | 1 |
| Norris, W | 1 |
| Kunzelman, KS | 1 |
| Bussell, S | 1 |
| Rohweder, L | 1 |
| Cochran, RP | 1 |
| Brunckhorst, CB | 1 |
| Bazhenov, AN | 1 |
| Kol'tsova, IV | 1 |
| Iaroshenko, GA | 1 |
| Bart, BIa | 1 |
| Pashkova, TL | 1 |
| Stepanov, NG | 1 |
| Orlova, TV | 1 |
| Kalmanova, EN | 1 |
| Rumeau, M | 1 |
| Pourrat, J | 1 |
| Chambeu, Y | 1 |
| Livshits, IB | 1 |
| Morgan, DB | 1 |
| Davidson, C | 1 |
| Nechwatal, W | 1 |
| Sigel, H | 1 |
| Bitter, F | 1 |
| Geffers, H | 1 |
| Kress, P | 1 |
| Adam, WE | 1 |
| Stauch, M | 1 |
| Bharani, A | 1 |
| Ganguly, A | 1 |
| Bhargava, KD | 1 |
| Stevens, MA | 1 |
| McCullough, PA | 1 |
| Tobin, KJ | 1 |
| Speck, JP | 1 |
| Westveer, DC | 1 |
| Guido-Allen, DA | 1 |
| Timmis, GC | 1 |
| O'Neill, WW | 1 |
| Wilhelmsen, L | 1 |
| Berglund, G | 1 |
| Sannerstedt, R | 1 |
| Hansson, L | 1 |
| Andersson, O | 1 |
| Sievertsson, R | 1 |
| Wikstrand, J | 1 |
| Houston, CS | 1 |
| Dickinson, J | 1 |
| Swartz, C | 1 |
| Kim, KE | 1 |
| Laslett, LJ | 1 |
| DeMaria, AN | 1 |
| Amsterdam, EA | 1 |
| Mason, DT | 1 |
| Henning, RJ | 1 |
| Weil, MH | 1 |
| Schenk, KE | 2 |
| Biamino, G | 2 |
| Schröder, R | 2 |
| Leitner, ER | 1 |
| Perchikova, GE | 1 |
| Tsibekmakher, TD | 1 |
| Somova, LV | 1 |
| Mitani, A | 1 |
| Shattock, MJ | 1 |
| Wehling, M | 1 |
| Zimmermann, J | 1 |
| Weil, J | 1 |
| Gerzer, R | 1 |
| Theisen, K | 1 |
| Bechler-Lisińska, J | 1 |
| Cholewa, M | 1 |
| Górski, L | 1 |
| Markiewicz, K | 1 |
| Nemirovskaia, MA | 1 |
| Zharov, EI | 1 |
| Vertkin, AL | 1 |
| Borchgrevink, PC | 1 |
| Jynge, P | 1 |
| Houston, MC | 1 |
| Johnston, PE | 1 |
| Weser, C | 1 |
| Scheidler, K | 1 |
| Teichmann, G | 1 |
| Löper, W | 1 |
| Kolff, J | 1 |
| Cheanvechai, C | 1 |
| Viljoen, JF | 1 |
| Sidorenko, BA | 2 |
| Kharchenko, VI | 2 |
| Titov, VN | 1 |
| Lotova, EV | 1 |
| Mel'nichenko, GA | 2 |
| Cohen, H | 1 |
| Langendorf, R | 1 |
| Pick, A | 1 |
| Rotsztain, A | 1 |
| Shugoll, GI | 1 |
| Lloyd, RA | 1 |
| Simon, H | 1 |
| Schweikert, U | 1 |
| Trübestein, G | 1 |
| Esser, H | 1 |
| Fricke, G | 1 |
| Croxson, MS | 1 |
| Neutze, JM | 1 |
| John, MB | 1 |
| Tolstykh, AN | 1 |
| Sanna, GP | 1 |
| Kliachko, VR | 1 |
| Shaginova, EM | 1 |
| Tirkina, TN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Renal Insufficiency Following Contrast Media Administration Trial III (REMEDIAL III): Renalguard System Versus Left-ventricular End-diastolic Pressure-guided Hydration in High-risk Patients for Contrast-induced Acute Kidney Injury[NCT02489669] | 700 participants (Anticipated) | Interventional | 2015-07-15 | Enrolling by invitation | |||
| Renal Insufficiency Following Contrast Media Administration Trial II (Remedial II): The RenalGuard System in High-Risk Patients for Contrast-Induced Acute Kidney Injury[NCT01098032] | Phase 3 | 294 participants (Actual) | Interventional | 2009-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The primary outcome measure will be the rate of development of CI-AKI in the 2 study arms (number of participants). CI-AKI is defined as an increase in the serum creatinine concentration >=0.3 mg/dL from the baseline value at 48 hours after administration of the contrast media or the need for dialysis. (NCT01098032)
Timeframe: at 48 hours following contrast exposure
| Intervention | participants (Number) |
|---|---|
| Systemic Alone Therapy Group | 146 |
| RenalGuard System Group | 146 |
1 review available for furosemide and Coronary Disease
| Article | Year |
|---|---|
Essential hypertension: new insights and controversies in treatment with diuretics.
Topics: Amiloride; Antihypertensive Agents; Blood Pressure; Coronary Disease; Diuretics; Dose-Response Relat | 1986 |
9 trials available for furosemide and Coronary Disease
| Article | Year |
|---|---|
Shenfu injection combined with furosemide in the treatment of chronic heart failure in patients with coronary heart disease: A protocol of randomized controlled trial.
Topics: Chronic Disease; Coronary Disease; Diuretics; Drug Therapy, Combination; Drugs, Chinese Herbal; Furo | 2021 |
Potassium supplementation, diet vs pills: a randomized trial in postoperative cardiac surgery patients.
Topics: Administration, Oral; Aged; Cardiac Surgical Procedures; Coronary Artery Bypass; Coronary Disease; D | 2004 |
Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Chemotherapy, Adjuvant; Chronic Disease; Coronary Disease; Cro | 1995 |
A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation.
Topics: Aged; Cardiotonic Agents; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Crysta | 1999 |
A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation.
Topics: Aged; Cardiotonic Agents; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Crysta | 1999 |
A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation.
Topics: Aged; Cardiotonic Agents; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Crysta | 1999 |
A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation.
Topics: Aged; Cardiotonic Agents; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Crysta | 1999 |
[Haemodynamic effects of furosemide and ethacrynic acid (author's transl)].
Topics: Acute Disease; Blood Pressure; Blood Vessels; Coronary Disease; Ethacrynic Acid; Furosemide; Heart; | 1975 |
[Nitroglycerin, furosemide and ethacrynic acid effect on hemodynamics in rest and during ergometric load in coronary disease patients].
Topics: Blood Pressure; Blood Volume; Cardiac Output; Coronary Disease; Ethacrynic Acid; Exercise Test; Furo | 1976 |
[Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure].
Topics: Atrial Natriuretic Factor; Blood Pressure; Cardiomyopathy, Dilated; Coronary Disease; Cyclic GMP; De | 1990 |
[Effect of vasodilator agents on the character and incidence of cardiac arrhythmia in chronic heart failure].
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Atrial Fibrillation; Captopril; Cardiac Output | 1990 |
[Effect of vasodilator agents on the effectiveness of the complex treatment of patients with ischemic heart disease and congestive heart failure].
Topics: Aged; Cardiomyopathy, Dilated; Clinical Trials as Topic; Coronary Disease; Digoxin; Drug Synergism; | 1989 |
29 other studies available for furosemide and Coronary Disease
| Article | Year |
|---|---|
[CLINICAL EXPERIENCES WITH FUROSEMIDE].
Topics: Coronary Disease; Diuretics; Furosemide; Geriatrics; Heart Diseases; Humans | 1965 |
[CME-EKG 17. Coronary heart disease and arrhythmia].
Topics: Aged; Coronary Disease; Diagnosis, Differential; Electrocardiography; Erythromycin; Furosemide; Hear | 2007 |
[Interaction of calcium drug and vitamin D3 with some medicines used in coronary heart disease therapy].
Topics: Calcium; Cholecalciferol; Coronary Disease; Diuretics; Drug Interactions; Female; Furosemide; Humans | 2008 |
[Dilatation (congestive) cardiomyopathy: clinical aspects, diagnosis and treatment].
Topics: Adolescent; Adult; Cardiomegaly; Cardiomyopathy, Dilated; Coronary Disease; Diagnosis, Differential; | 1984 |
[Effects of the PETN-piridoxylate combination in the long-term treatment of cardiac failure in the aged patient].
Topics: Aged; Coronary Disease; Digoxin; Drug Combinations; Drug Therapy, Combination; Furosemide; Heart Fai | 1983 |
[Effect of acute furosemide and sodium chloride load on the hormone level of the blood of ischemic heart disease patients].
Topics: Adult; Coronary Disease; Female; Furosemide; Homeostasis; Hormones; Humans; Hyperlipoproteinemia Typ | 1982 |
Hypokalaemia and diuretics: an analysis of publications.
Topics: Chlorothiazide; Chlorthalidone; Coronary Disease; Diuretics; Dose-Response Relationship, Drug; Furos | 1980 |
[Global and regional left ventricular function in coronary heart disease after beta-blockade and furosemide (author's transl)].
Topics: Adult; Coronary Disease; Furosemide; Heart; Heart Ventricles; Humans; Middle Aged; Penbutolol; Physi | 1980 |
Effect of treatment of hypertension in the primary preventive trial, Göteborg, Sweden.
Topics: Adrenergic beta-Antagonists; Bethanidine; Cardiovascular Diseases; Cerebrovascular Disorders; Corona | 1979 |
Cerebral form of high-altitude illness.
Topics: Adult; Altitude Sickness; Betamethasone; Brain Edema; Bronchopneumonia; Coronary Disease; Dexamethas | 1975 |
Treatment of complicated hypertension.
Topics: Acute Disease; Cerebral Hemorrhage; Cerebrovascular Disorders; Chronic Disease; Coronary Disease; Di | 1977 |
Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy.
Topics: Aged; Coronary Disease; Digitalis Glycosides; Female; Furosemide; Heart Failure; Humans; Hydralazine | 1978 |
Effect of afterload reduction on plasma volume during acute heart failure.
Topics: Acute Disease; Aged; Blood Pressure; Cardiac Output; Coronary Disease; Diastole; Drug Evaluation; Fe | 1978 |
Diazoxide therapy: use and risks.
Topics: Angina Pectoris; Blood Pressure; Coronary Disease; Diazoxide; Dose-Response Relationship, Drug; Drug | 1976 |
[Treatment of refractory chronic circulatory insufficiency].
Topics: Adult; Aged; Benzothiadiazines; Cardiac Glycosides; Cardiomyopathies; Chronic Disease; Coronary Dise | 1976 |
[Treatment of resistant forms of cardiac insufficiency with a combination of diuretics].
Topics: Chlorine; Circadian Rhythm; Clopamide; Coronary Disease; Diuresis; Diuretics; Drug Synergism; Drug T | 1975 |
Role of Na-activated K channel, Na-K-Cl cotransport, and Na-K pump in [K]e changes during ischemia in rat heart.
Topics: Animals; Carrier Proteins; Coronary Disease; Diastole; Extracellular Space; Furosemide; Heart; Heart | 1992 |
Prolonged diuretic administration and myocardial tolerance to ischaemia.
Topics: Adenosine Triphosphate; Amiloride; Animals; Coronary Circulation; Coronary Disease; Diuretics; Elect | 1987 |
[Differential treatment of coronary heart disease].
Topics: Angina Pectoris; Aspirin; Cardiac Glycosides; Coronary Disease; Dipyridamole; Furosemide; Heparin; H | 1974 |
[Use, association and contraindications of hypotensive drugs].
Topics: Antihypertensive Agents; Blood Pressure; Coronary Disease; Diuretics; Furosemide; Ganglionic Blocker | 1969 |
Effective use of positive end expiratory pressure.
Topics: Adult; Angina Pectoris; Coronary Artery Bypass; Coronary Disease; Female; Furosemide; Humans; Hypoxi | 1974 |
[Comparison of the effectiveness and mechanism of action of the saluretic preparations triamterene and hypothiazide and their combination (triampur) in circulatory insufficiency].
Topics: Acid-Base Equilibrium; Adult; Aged; Arteriosclerosis; Circadian Rhythm; Coronary Disease; Creatinine | 1973 |
Intermittent parasystole--mechanism of protection.
Topics: Aged; Aminosalicylic Acids; Arrhythmias, Cardiac; Arteriosclerosis; Cerebrovascular Disorders; Coron | 1973 |
Hypoxemia in acute myocardial infarction and in coronary insufficiency.
Topics: Adult; Aged; Arteries; Coronary Disease; Furosemide; Humans; Hypoxia; Male; Middle Aged; Myocardial | 1973 |
[Serum magnesium in patients with myocardial insufficiency under treatment with glycosides and furosemide].
Topics: Adult; Colorimetry; Coronary Disease; Furosemide; Glycosides; Humans; Magnesium; Male; Potassium | 1972 |
Exchangeable potassium in heart disease: long-term effects of potassium supplements and amiloride.
Topics: Adult; Aged; Amiloride; Coronary Disease; Diuretics; Erythrocytes; Female; Furosemide; Heart Disease | 1972 |
[Comparison of the effectiveness and mechanism of action of the saluretics lasix, ethacrynic acid, brinaldix and triamterene in congestive cardiac insufficiency].
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Coronary Disease; Diuretics; Ethacrynic Acid; Female; Fur | 1971 |
[Modern and rational use of diuretics in cardiology].
Topics: Coronary Disease; Diuretics; Ethacrynic Acid; Furosemide; Glucocorticoids; Heart Diseases; Humans; K | 1969 |
[Effect of saluretics on carbohydrate metabolism].
Topics: Adolescent; Adult; Carbohydrate Metabolism; Coronary Disease; Diabetes Mellitus; Diuretics; Furosemi | 1970 |